Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$2.2 1.62%
Market Cap
$7.6M
Price Target
Refer to Report
Volume
162.3K
52wk Range
$2.05 - $27.3
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.